Your browser doesn't support javascript.
loading
Tulobuterol is a potential therapeutic drug in congenital myasthenic syndrome.
Miyana, Kaori; Ishiyama, Akihiko; Saito, Yoshihiko; Nishino, Ichizo.
Affiliation
  • Miyana K; Department of Pediatrics, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Ishiyama A; Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Saito Y; Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Nishino I; Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Pediatr Int ; 64(1): e15115, 2022 01.
Article in En | MEDLINE | ID: mdl-35396808
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myasthenic Syndromes, Congenital Limits: Humans Language: En Journal: Pediatr Int Journal subject: PEDIATRIA Year: 2022 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myasthenic Syndromes, Congenital Limits: Humans Language: En Journal: Pediatr Int Journal subject: PEDIATRIA Year: 2022 Document type: Article Affiliation country: Japón